Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer

Checkpoint kinase 1 (Chk1) expression is enhanced in most cancers owing to oncogenic activation and constant replicative stress. Chk1 inactivation is a promising cancer therapy, as its inactivation leads to genomic instability, chromosomal catastrophe, and cancer cell death. Herein, we observed that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sera, Kim, Yesol, Lee, Soo-Been, Kang, Hyeok-Gu, Kim, Da-Hyun, Park, Jee Won, Chung, Daeun, Kong, Hyunkyung, Yoo, Kyung Hyun, Kim, Yonghwan, Han, Wonshik, Chun, Kyung-Hee, Park, Jong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548284/
https://www.ncbi.nlm.nih.gov/pubmed/33041328
http://dx.doi.org/10.1038/s41389-020-00275-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548284/
https://www.ncbi.nlm.nih.gov/pubmed/33041328
http://dx.doi.org/10.1038/s41389-020-00275-x

Ejemplares similares